XK469R

XK469R · National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XK469R, covering 2013-02-08 to 2013-02-08. Get the full timeline:

Most recent: Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]